Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $551.5 million versus the consensus estimate of $527.2 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.